Treatment of Type I Supracondylar Fractures of the Humerus
NCT ID: NCT00904137
Last Updated: 2018-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2009-05-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Splinting Versus Casting for Type I Supracondylar Fractures
NCT01912365
Management of Type 1 Supracondylar Humeral Fractures
NCT04642807
The Use of Telemedicine Tool in Supracondylar Humerus Fractures in Children
NCT02640027
HM vs Fibreglass Cast Immbolization for Supracondylar Fractures
NCT05430074
Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study
NCT02963233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cast
Above elbow fiberglass cast with a collar-and-cuff
Cast
Splint
Long arm posterior plaster splint with a collar-and-cuff
Splint
Tape
Elastoplast tape applied to keep the elbow in flexion, with a collar-and-cuff
Tape
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cast
Splint
Tape
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* a pre-existing diagnosis of metabolic or structural bone disease that predisposes them to fractures
* presence of other fractures of the ipsilateral upper extremity
4 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kishore Mulpuri
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kishore Mulpuri
Role: PRINCIPAL_INVESTIGATOR
University of British Columbia
Renjit Varghese
Role: STUDY_DIRECTOR
University of British Columbia
Lisa Dyke
Role: STUDY_DIRECTOR
University of British Columbia
Firoz Miyanji
Role: STUDY_DIRECTOR
University of British Columbia
Christopher Reilly
Role: STUDY_DIRECTOR
University of British Columbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
BC Children's Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H08-02904
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.